文献速递针灸推拿中医康复

微针刀治疗紧张型头痛的临床疗效与安全性:系统评价与Meta分析

Clinical Efficacy and Safety of Miniscalpel-Needle Treatment for Tension-Type Headache: A Systematic Review and Meta-Analysis.
PubMed 文献 · Chin J Integr Med · 2020-03-13

该系统评价纳入7项RCT共724例紧张型头痛患者,比较微针刀(MSN)与针刺或常规治疗的效果。MSN单用较针刺显著提高显效率和痊愈率,但不提高总有效率;MSN联合常规治疗较常规治疗显著降低VAS评分并提高总有效率、显效率和痊愈率。因纳入研究数量少、样本量小且方法学质量差,结果需谨慎解读。

要点

  • MSN单用较针刺可提高显效率和痊愈率,但总有效率无显著差异。
  • MSN联合常规治疗较常规治疗可降低VAS评分并提高总有效率、显效率和痊愈率。
  • 纳入研究数量少、样本量小、方法学质量差,证据置信度低。

核心结论

  • 根据当前证据,MSN作为单一疗法或作为其他现有疗法的辅助治疗可能对紧张型头痛有益。
  • 由于纳入研究数量少、样本量小且方法学质量差,本综述结果应非常谨慎解读,对结果的置信度低。

研究设计与样本

  • 共纳入7项RCT,涉及724例参与者。

主要发现

  • 与针刺相比,MSN治疗的显效率RR 1.27(95%CI 1.01至1.61),痊愈率RR 1.31(95%CI 1.09至1.57),总有效率RR 1.03(95%CI 0.96至1.10)。
  • 与常规治疗相比,MSN联合常规治疗的VAS评分平均差-3.54(95%CI -3.80至-3.28),总有效率RR 1.14(95%CI 1.06至1.23),显效率RR 2.31(95%CI 1.50至3.58),痊愈率RR 3.01(95%CI 2.25至4.02)。

关键数值与推荐

  • 主要结局为视觉模拟量表(VAS)或数字评定量表(NRS)评分。
  • 次要结局包括临床有效率(总有效率TER、显效率MER、痊愈率TCR)、不良事件发生频率和生活质量。

临床怎么用

  • MSN可作为紧张型头痛的单用或辅助治疗选择,但需结合患者具体情况谨慎使用。
  • 临床决策时应考虑当前证据质量低,需与患者充分沟通证据不确定性。

局限性

  • 纳入研究数量少且样本量小。
  • 纳入研究的方法学质量差。
  • 对结果的置信度低,需高质量RCT进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the clinical efficacy and safety of miniscalpel-needle (MSN) treatment for tension-type headache (TTH). METHOD: Seven medical databases were searched to identify randomized controlled trials (RCTs) evaluating the effect and safety of MSN treatment. All articles published up to November 15, 2018 were retrieved. A meta-analysis was conducted for the included studies, and the risk of bias was assessed. Primary outcomes were visual analogue scale (VAS) or numeric rating scale (NRS) score. Secondary outcomes were clinical effective rates including total effective rate (TER), markedly effective rate (MER), and totally cured rate (TCR) determined by improvement in clinical symptoms or VAS scores, the frequency of adverse events (AEs) that occurred during the study, and participant quality of life (QOL). RESULTS: Seven RCTs involving 724 participants were included. MSN treatment showed significantly higher MER and TCR [relative risk (RR) 1.27, 95% confidence interval (CI) 1.01 to 1.61; RR 1.31, 95% CI 1.09 to 1.57, respectively], but not TER (RR 1.03, 95% CI 0.96 to 1.10) compared to acupuncture. MSN treatment plus conventional treatment showed significant lower VAS and higher TER, MER, and TCR (mean difference -3.54, 95% CI -3.80 to -3.28; RR 1.14, 95% CI 1.06 to 1.23; RR 2.31, 95% CI 1.50 to 3.58; RR 3.01, 95% CI 2.25 to 4.02, respectively) compared to conventional treatment. CONCLUSIONS: According to current evidence, MSN treatment as a monotherapy or as an adjunctive treatment to other existing treatments might have benefits on treating TTH. However, since the number and the sample size of studies included were both small and the methodological quality was poor, the findings of this review should be interpreted with great caution, and our confidence in the results is low. A high quality RCT using objective outcomes should be performed on this topic.

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Kwon CY, Yoon SH, Chung SY, et al. Clinical Efficacy and Safety of Miniscalpel-Needle Treatment for Tension-Type Headache: A Systematic Review and Meta-Analysis. Chin J Integr Med. 2020. PMID: 32170522. doi:10.1007/s11655-020-3179-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。